RGS4 and GAIP are GTPase-activating proteins for G and block activation of phospholipase Cβ by γ-thio-GTP-G

  1. John R. Hepler*,
  2. David M. Berman,
  3. Alfred G. Gilman, and
  4. Tohru Kozasa
  1. Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75235-9041

Abstract

RGS proteins constitute a newly appreciated and large group of negative regulators of G protein signaling. Four members of the RGS family act as GTPase-activating proteins (GAPs) with apparent specificity for members of the G subfamily of G protein subunits. We demonstrate here that two RGS proteins, RGS4 and GAIP, also act as GAPs for G, the Gα protein responsible for activation of phospholipase Cβ. Furthermore, these RGS proteins block activation of phospholipase Cβ by guanosine 5′-(3-O-thio)triphosphate-G. GAP activity does not explain this effect, which apparently results from occlusion of the binding site on Gα for effector. Inhibitory effects of RGS proteins on G protein-mediated signaling pathways can be demonstrated by simple mixture of RGS4 or GAIP with plasma membranes.

Footnotes

  • * Present address: Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322.

  • To whom reprint requests should be addressed.

  • Alfred G. Gilman

  • Abbreviations: GAP, GTPase-activating protein; GTPγS, guanosine 5′-(3-O-thio)triphosphate; PGE1, prostaglandin E1.

« Previous | Next Article »Table of Contents